Literature DB >> 17401519

Varicella-zoster virus at relapses of multiple sclerosis.

Julio Sotelo1, Graciela Ordoñez, Benjamin Pineda.   

Abstract

The possible participation of different herpes viruses was studied during exacerbations of multiple sclerosis (MS). We searched for the presence of DNA from the following herpes viruses: varicella zoster virus (VZV), herpes-simplex viruses 1 and 2; Epstein-Barr virus (EBV) and human herpes-virus-6 (HHV6) in mononuclear cells from patients with MS during relapse (n = 40), MS during remission (n = 131) and controls (n = 125). Additionally, immune cells containing viral antigens were quantified by flow cytometry, and VZV load was determined by real time PCR in 2 MS patients at various times during relapse and remission. DNA from VZV was found in 95% of MS patients during relapse and in 17% during remission; all controls were negative; by contrast, DNA from HHV6 was found in 24% of MS patients during relapse and in 2% during remission; DNA from herpes simplex viruses was not found in any subject; and DNA from EBV was found in a similar percentage of subjects from all groups. Sequential quantification of VZV-load showed a curve that increased during relapse and disappeared at remission. Also, VZV antigens were found inside a large number of immune cells from MS patients during relapse as compared with MS patients on remission and controls. In the typical forms of VZV infection, varicella and herpes-zoster, DNA from VZV is found in mononuclear cells exclusively during brief periods at the beginning of the active infection, but not during latency; thus, the conspicuous presence of VZV during relapses of MS may indicate a period of active infection and suggests the participation of VZV in the pathogenesis of MS.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17401519     DOI: 10.1007/s00415-006-0402-x

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  45 in total

1.  The epidemiology of varicella hospitalizations in the U.S. Army.

Authors:  T Lee; R N Nang
Journal:  Mil Med       Date:  2000-10       Impact factor: 1.437

2.  Flow cytometric method for the detection of gpI antigens of varicella zoster virus and evaluation of anti-VZV agents.

Authors:  R Snoeck; D Schols; C Sadzot-Delvaux; J M Cloes; G Andrei; E De Clercq; J Piette; B Rentier
Journal:  J Virol Methods       Date:  1992-08       Impact factor: 2.014

Review 3.  Persistence of the Epstein-Barr virus and the origins of associated lymphomas.

Authors:  David A Thorley-Lawson; Andrew Gross
Journal:  N Engl J Med       Date:  2004-03-25       Impact factor: 91.245

4.  Chickenpox and multiple sclerosis: a case report.

Authors:  M Rösener; J Dichgans; R Martin; F Harms
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-05       Impact factor: 10.154

5.  A randomized, double-blind, placebo-controlled MRI study of anti-herpes virus therapy in MS.

Authors:  E Bech; J Lycke; P Gadeberg; H J Hansen; C Malmeström; O Andersen; T Christensen; S Ekholm; S Haahr; P Höllsberg; T Bergström; B Svennerholm; J Jakobsen
Journal:  Neurology       Date:  2002-01-08       Impact factor: 9.910

6.  Detection of viral DNA and immune responses to the human herpesvirus 6 101-kilodalton virion protein in patients with multiple sclerosis and in controls.

Authors:  Maria V Tejada-Simon; Ying C Q Zang; Jian Hong; Victor M Rivera; James M Killian; Jingwu Z Zhang
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

Review 7.  What does epidemiology tell us about risk factors for herpes zoster?

Authors:  Sara L Thomas; Andrew J Hall
Journal:  Lancet Infect Dis       Date:  2004-01       Impact factor: 25.071

Review 8.  Varicella zoster virus latency, neurological disease and experimental models: an update.

Authors:  Randall J Cohrs; Donald H Gilden; Ravi Mahalingam
Journal:  Front Biosci       Date:  2004-01-01

9.  Brief presence of varicella-zoster vral DNA in mononuclear cells during relapses of multiple sclerosis.

Authors:  Graciela Ordoñez; Benjamin Pineda; Roberto Garcia-Navarrete; Julio Sotelo
Journal:  Arch Neurol       Date:  2004-04

10.  Is the frequency of multiple sclerosis increasing in Mexico?

Authors:  O Gonzalez; J Sotelo
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-11       Impact factor: 10.154

View more
  19 in total

Review 1.  Viruses and multiple sclerosis.

Authors:  Gregory P Owens; Don Gilden; Mark P Burgoon; Xiaoli Yu; Jeffrey L Bennett
Journal:  Neuroscientist       Date:  2011-12       Impact factor: 7.519

2.  Assessment of Epstein-Barr virus in blood from patients with multiple sclerosis.

Authors:  Gloudina M Hon; Mogamat S Hassan; Susan J van Rensburg; Rajiv T Erasmus; Tandi E Matsha
Journal:  Metab Brain Dis       Date:  2012-03-10       Impact factor: 3.584

3.  Antibodies in multiple sclerosis oligoclonal bands target debris.

Authors:  Ryan C Winger; Scott S Zamvil
Journal:  Proc Natl Acad Sci U S A       Date:  2016-06-28       Impact factor: 11.205

4.  Identification of human herpesviruses 1 to 8 in Tunisian multiple sclerosis patients and healthy blood donors.

Authors:  Nadia Ben Fredj; Antonella Rotola; Faten Nefzi; Saber Chebel; Roberta Rizzo; Elisabetta Caselli; Mahbouba Frih-Ayed; Dario Di Luca; Mahjoub Aouni
Journal:  J Neurovirol       Date:  2011-11-05       Impact factor: 2.643

5.  Relation between Epstein-Barr virus and multiple sclerosis: analytic study of scientific production.

Authors:  O Santiago; J Gutierrez; A Sorlozano; J de Dios Luna; E Villegas; O Fernandez
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-04-29       Impact factor: 3.267

6.  Varicella zoster virus is not a disease-relevant antigen in multiple sclerosis.

Authors:  Mark P Burgoon; Randall J Cohrs; Jeffrey L Bennett; Sarah W Anderson; Alanna M Ritchie; Sabine Cepok; Bernhard Hemmer; Don Gilden; Gregory P Owens
Journal:  Ann Neurol       Date:  2009-04       Impact factor: 10.422

7.  Clone clusters in autoreactive CD4 T-cell lines from probable multiple sclerosis patients form disease-characteristic signatures.

Authors:  Mathilda Mandel; Anat Achiron; Tamir Tuller; Tilda Barliya; Gideon Rechavi; Ninette Amariglio; Ron Loewenthal; Gad Lavie
Journal:  Immunology       Date:  2009-10       Impact factor: 7.397

Review 8.  Viruses and multiple sclerosis.

Authors:  Jussi Oskari Virtanen; Steve Jacobson
Journal:  CNS Neurol Disord Drug Targets       Date:  2012-08       Impact factor: 4.388

9.  Varicella zoster virus and relapsing remitting multiple sclerosis.

Authors:  Julio Sotelo; Teresa Corona
Journal:  Mult Scler Int       Date:  2011-03-30

10.  Epstein-Barr virus stimulates torque teno virus replication: a possible relationship to multiple sclerosis.

Authors:  Silvia S Borkosky; Corinna Whitley; Annette Kopp-Schneider; Harald zur Hausen; Ethel-Michele de Villiers
Journal:  PLoS One       Date:  2012-02-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.